Business, Policy & Funding
Breaking news on Precision Oncology business, policy & funding.
In Brief This Week: Carisma Therapeutics, Proteomedix, American Cancer Society
News items for the week of Sept. 20, 2021.
Novartis's Advanced Accelerator Applications Licenses Theragnostics' Gallium-68 Platform
The Novartis subsidiary licensed Theragnostics' Gallium-68 platform to support its growing pipeline of radiopharmaceutical products.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.
Grail Gets NY State Department of Health Approval for Galleri Multicancer Test
Galleri is designed to detect more than 50 cancer types through a routine blood draw and, when a cancer signal is detected, predict its origin.
Based on insights gleaned from earlier trials of its Granite and Slate neoantigen immunotherapies, the company is improving the design of its vaccines and homing in on best responders.
Sep 17, 2021
In Brief This Week: Zai Lab, Roche, Realm IDx
Sep 17, 2021